Elderly onset age is associated with low efficacy of first anti-tumor necrosis factor treatment in patients with inflammatory bowel disease

The outcomes of patients with elderly onset (EO) inflammatory bowel disease (IBD) treated with anti-tumor necrosis factor (TNF) remains uncertain. The present study evaluated the efficacy and safety of anti-TNF treatment for bio-naïve EO-IBD. Elderly patients were defined as those 60 years and older...

Descripción completa

Detalles Bibliográficos
Autores principales: Amano, Takahiro, Shinzaki, Shinichiro, Asakura, Akiko, Tashiro, Taku, Tani, Mizuki, Otake, Yuriko, Yoshihara, Takeo, Iwatani, Shuko, Yamada, Takuya, Sakakibara, Yuko, Osugi, Naoto, Ishii, Shuji, Egawa, Satoshi, Araki, Manabu, Arimoto, Yuki, Nakahara, Masanori, Murayama, Yoko, Kobayashi, Ichizo, Kinoshita, Kazuo, Ogawa, Hiroyuki, Hiyama, Satoshi, Shibukawa, Narihiro, Komori, Masato, Okuda, Yorihide, Kizu, Takashi, Yoshii, Shunsuke, Tsujii, Yoshiki, Hayashi, Yoshito, Inoue, Takahiro, Iijima, Hideki, Takehara, Tetsuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964802/
https://www.ncbi.nlm.nih.gov/pubmed/35351986
http://dx.doi.org/10.1038/s41598-022-09455-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964802/
https://www.ncbi.nlm.nih.gov/pubmed/35351986
http://dx.doi.org/10.1038/s41598-022-09455-8

Ejemplares similares